The Next Generation Colposcope with an Advanced Cervical Scan

DYSISmap is an adjunctive technology to assist colposcopy

The DYSIS Colposcope is a high resolution digital colposcope with an adjunctive map. The DYSISmap is generated by a proprietary technology that measures the aceto-whitening reaction and summarises it in the form of an intuitive map. The DYSISmap is overlaid on the live image of the cervix to help with the identification of the most relevant biopsy sites.

DYSIS adopted by JPS Heath for Residency Education


JPS Health adopts DYSIS Cervical Imaging for Residency Education

Edinburgh, Scotland – February 13, 2017 – DYSIS Medical, Ltd. announced today that JPS Health Network, a leading innovator in health care in Fort Worth, Texas, purchased the DYSIS Advanced Cervical Imaging System for the Northwest Health Center for Women and Children, which serves as a clinical training site for OB/GYN residents at JPS.

DYSIS is a clinically proven next-generation colposcope used to assess women after an abnormal Pap smear. The DYSIS imaging technology produces an intuitive color-coded map that assists physicians and residents in identifying, documenting and biopsying abnormal areas of the cervix and standardizes the procedure to make it more objective and accurate.

Clinical studies in Europe and the U.S. IMPROVE-COLPO study have demonstrated that when the map is added to a standard exam, detection of high grade disease is substantially increased.  In addition, a Global Patient Experience Survey of over 1,000 women has demonstrated that women strongly prefer DYSIS over traditional colposcopic exams.

DYSIS Medical’s CEO, Alastair Atkinson commented, “We are thrilled that another important residency program has adopted DYSIS for its potential to significantly improve quality, digital documentation for patient management, and patient and resident education.  JPS joins several hundred other facilities who have purchased DYSIS worldwide, many of which are academic institutions.”


DYSIS Medical Ltd

DYSIS Medical Ltd has its global headquarters in Edinburgh. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit:


Women’s Care Florida adopted a DYSIS Colposcope to improve their standard of care. Dr Kapitz tells us how it has improved cervical…
Dr KapitzWomen's Care FloridaPlay Video  Dr Kapitz


Dr Fellenbaum tells us how the DYSIS Colposcope has helped to offer his patient's the best care possible.
Dr Theodore FellenbaumFlint OBGYNPlay Video  Dr Theodore Fellenbaum


Donovan Miske tells us how the DYSIS Colposcope has increased the level of care across all 3 of the practice locations.
Donovan Miske – Practice ManagerFlint OB/GYN (Flint, MI)Play Video  onovan Miske – Practice Manager